ER study aims to stop patients being trapped awake while paralyzed

NCT ID NCT05534243

First seen Mar 28, 2026 · Last updated May 16, 2026 · Updated 6 times

Summary

This study looks at whether using a short-acting paralytic drug (succinylcholine) instead of a longer-acting one (rocuronium) can prevent patients from being awake and aware while paralyzed on a breathing machine in the emergency room. About 3,090 adults on ventilators will take part across five hospitals. The goal is to reduce the risk of post-traumatic stress disorder (PTSD) linked to this terrifying experience.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PTSD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cooper University Hospital/Cooper Medical School of Rowan University

    RECRUITING

    Camden, New Jersey, 08103, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hennepin Healthcare

    RECRUITING

    Minneapolis, Minnesota, 55415, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Roy J. and Lucille A. Carver College of Medicine

    RECRUITING

    Iowa City, Iowa, 52242, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Washington School of Medicine

    RECRUITING

    Seattle, Washington, 98195, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.